SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001136261-17-000085
Filing Date
2017-05-01
Accepted
2017-05-01 16:15:31
Documents
4
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A body10ka.htm 10-K/A 305808
2 CEO 302 CERTIFICATE exh31-1.htm EX-31.1 2151
3 CFO 302 CERTIFICATE exh31-2.htm EX-31.2 1878
4 LOGO image1904.jpg GRAPHIC 6415
  Complete submission text file 0001136261-17-000085.txt   319953
Mailing Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960
Business Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960 (862) 260-8457
PERNIX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001024126 (see all company filings)

IRS No.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-14494 | Film No.: 17800884
SIC: 2834 Pharmaceutical Preparations